← Back
Research Paper Volume 15, Issue 15 pp 7831—7843

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma

class="figure-viewer-img"

Figure 5. GO analysis of intersection target.